Biotek-snakken — December 2020
-
Mens Orphazyme ligger på årets laveste:( Medwatch: https://medwatch.dk/Medicinal___Biotek/article12600722.ece?utm_source=Feed&utm_medium=latest
-
...og samme fra investor news - https://ml-eu.globenewswire.com/Resource/Download/0fb226ec-3bf5-4779-a34e-30cbaa248402
-
Endnu en dag, endnu en nyhed fra Zymeworks
Exelixis udnytter option på ICON-2
https://ir.zymeworks.com/News-Releases/news-details/2020/Exelixis-In-Licenses-Iconic-Therapeutics-Tissue-Factor-Targeting-Antibody-Drug-Conjugate-Ahead-of-Planned-Investigational-New-Drug-Application/default.aspx -
Scandion Onkology præsentation: https://www.biostock.se/2020/12/biostock-studio-scandion-oncology-outlines-vision-to-fight-cancer-drug-resistance/
-
En investors spændende tanker om $TRIL og konkurrenter i CD47. https://drive.google.com/file/d/1izk0BFPtslVRCsui3VzElU2lTNqrA16p/view
-
God nat:)
-
Det bliver spændende med Sutros STRO-002 data i dag. Webcast kl. 23.00
-
Hansa Biopharma hos ØU. Nu med link som virker: https://vimeo.com/483997561?mc_eid=513463285b&mc_cid=87d7874648
-
"Redmile, som är ett amerikanskt venture
capital-bolag inriktat på hälsovård, har köpt ytterligare aktier i Hansa Biopharma varefter innehavet uppgår till drygt 4,6 miljoner aktier, motsvarande nästan 10,1 procent av aktiekapitalet och 10,4 procent av rösterna". https://www.avanza.se/placera/telegram/2020/11/30/hansa-biopharma-redmile-okat-ytterligare-nu-over-10-av-kap.html
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind